ICD10monitor February 1, 2023
Mark Spivey

The federal agency announced this week that it has updated its policies for the MA RADV program.

Echoing an intensifying drumbeat of criticism heard from providers, whistleblowers, consumers, and advocacy groups, the New York Times turned a witheringly scrutinous eye to the Medicare Advantage (MA) program in a feature article last October, saying that a “review of dozens of fraud lawsuits, inspector general audits and investigations by watchdogs shows how major health insurers exploited the program to inflate their profits by billions of dollars.”

So it may not have come as a surprise when federal officials this week announced that they were taking a similarly inquisitive look.

The Centers for Medicare & Medicaid Services (CMS) issued a press release announcing...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage, Payer, Provider
CMS releases final rule for 2026 Medicare Advantage, prescription drug plans
APG Report Calls for Major Reforms to Medicare, Medicare Advantage
The fastest-growing Medicare Advantage startup plans in 2025
Time To Reexamine The Role Of Supplemental Benefits In Medicare Advantage
Fastest-growing nonprofit Medicare Advantage plans | 2025

Share This Article